Turacoz Group Unveils AI Innovations in Evidence Synthesis at World EPA Congress 2025

The Turacoz Group has once again positioned itself at the forefront of healthcare innovation by presenting their AI-powered living systematic reviews (LSRs) during the World Evidence, Pricing, and Access (EPA) Congress, which took place in Europe in March 2025. This event gathered leaders from around the globe to discuss and explore the latest strategies for market access and the revolutionary impact of AI on evidence synthesis.

Transforming Evidence with AI

Dr. Namrata Singh, the visionary Founder and CEO of Turacoz Group, captivated attendees with her presentation titled "Revolutionizing Evidence Synthesis – The Role of Artificial Intelligence in Living Systematic Reviews (LSRs)." In addition to her talk, Turacoz showcased a scientific poster detailing AI-driven methodologies that continue to shape the landscape of medical research and health economics.

The essence of Dr. Singh's presentation lay in how automation and machine learning are pivotal in transforming the way evidence is synthesized. These advancements enable continuous updates to literature, significantly enhancing healthcare decision-making processes. She emphasized the necessity for innovative methodologies in gathering, synthesizing, and disseminating reliable evidence, particularly amidst vast data sources.

The Role of Real-World Evidence

As the healthcare industry sees an increasing demand for real-time, high-quality data, Turacoz's approach relies on AI-driven systematic literature reviews, detection algorithms for bias, and adaptive meta-analyses. These technologies have begun to redefine post-market surveillance, health technology assessments, and comparative effectiveness research, ultimately leading to improvements in efficiency and accuracy of healthcare insights.

"In today's fast-paced environment, having accurate, timely, and accessible data is crucial for informed decision-making. AI solutions enhance these attributes, empowering healthcare professionals to provide better patient care and achieve scientific advancements," stated Dr. Singh.

Comprehensive Support for Healthcare Stakeholders

Turacoz Group leverages its vast expertise in AI-powered real-world evidence (RWE) and health economics and outcomes research (HEOR). They provide strategic support in areas such as data analytics, systematic reviews, medical writing, and regulatory submissions. This multifaceted support helps organizations navigate complex healthcare landscapes, showcasing the value and impacts of various medical interventions.

By focusing on generating high-quality evidence and conducting thorough health economics research, Turacoz helps boost data-driven decision-making across the biopharma, medtech, and healthcare industries. Their commitment to innovation is evident as they empower stakeholders to make informed choices that enhance patient outcomes and optimize market access strategies.

About Turacoz Group

Turacoz Group specializes in forming partnerships with biopharmaceutical companies, medical technology firms, healthcare professionals, and research institutes. Their expertise lies in ensuring that complex data is communicated clearly and effectively across various formats, both digital and print. By offering insights derived from real-world data and systematic reviews, Turacoz enables clients to make informed, evidence-based decisions that promote innovation and improve patient care.

As the Congress concluded, it was clear that Turacoz Group, through its dedication to technological advancements, stands ready to continue leading the charge in healthcare innovation, driving meaningful improvements in patient outcomes and the efficiency of healthcare delivery.

For more information about Turacoz and its services, please reach out via their official contact channels.